Wall Street Zen cut shares of Sol Strategies (NASDAQ:STKE – Free Report) from a sell rating to a strong sell rating in a report released on Sunday,Wall Street Zen reports.
A number of other equities analysts have also recently weighed in on STKE. Cantor Fitzgerald upped their price target on Sol Strategies from $2.80 to $6.20 and gave the stock an “overweight” rating in a report on Thursday. Weiss Ratings lowered shares of Sol Strategies from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday, August 14th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $6.20.
Check Out Our Latest Report on Sol Strategies
Sol Strategies Price Performance
Institutional Trading of Sol Strategies
An institutional investor recently raised its position in Sol Strategies stock. Key Client Fiduciary Advisors LLC increased its holdings in Sol Strategies (NASDAQ:STKE – Free Report) by 7.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 356,387 shares of the company’s stock after acquiring an additional 25,800 shares during the quarter. Key Client Fiduciary Advisors LLC’s holdings in Sol Strategies were worth $417,000 as of its most recent filing with the SEC.
About Sol Strategies
Sol Strategies Inc is a company focused on building and supporting infrastructure and services for the Solana blockchain ecosystem. Its business is centered on providing exposure to and operational support for digital asset network participation, including activities associated with staking and related blockchain infrastructure.
The company has positioned itself as part of the broader cryptocurrency and decentralized finance landscape, where blockchain validators and staking operations play a role in helping secure proof-of-stake networks.
Featured Stories
- Five stocks we like better than Sol Strategies
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Sol Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sol Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
